The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Oct. 05, 2018
Applicants:

Vib Vzw, Ghent, BE;

Universiteit Gent, Ghent, BE;

Inventors:

Nico L. M. Callewaert, Nevele, BE;

Francis Santens, Ghent, BE;

Assignees:

VIB VZW, Ghent, BE;

Universiteit Gent, Ghent, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C12N 9/24 (2006.01); C12P 21/00 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2402 (2013.01); C07K 16/2887 (2013.01); C12P 21/005 (2013.01); C12Y 302/01096 (2013.01); C07K 2317/41 (2013.01); C07K 2317/71 (2013.01); C07K 2317/732 (2013.01); C07K 2317/94 (2013.01); C07K 2319/30 (2013.01);
Abstract

The present application relates to the field of glyco-engineering, more specifically to glyco-engineering of Fc-containing molecules, such as antibodies. It is shown herein that Fc-containing molecules with a specific glycosylation pattern have a considerably longer circulating half-life in vivo, without having an altered binding affinity for their respective antigen. This has therapeutic implications in reducing the frequency with which these molecules need to be administered, without affecting therapeutic efficacy. Also, cells are provided that can produce the Fc molecules with the desired glycosylation pattern.


Find Patent Forward Citations

Loading…